Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer

Anca Chelariu-Raicu, Charles F. Levenback, Brian M. Slomovitz, Judith Wolf, Diane C. Bodurka, John J. Kavanagh, Christopher Morrison, David M. Gershenson, Robert L. Coleman

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences